Bictegravir Sodium, Emtricitabine, and Tenofovir Alafenamide Fumarate and Lemtrada

• Generic Name: bictegravir / emtricitabine / tenofovir alafenamide
• Dosage Forms: n.a.
• Other Brand Names: Biktarvy

Treatment of HIV-1 infection in antiretroviral-naive (have not previously received antiretroviral therapy) or antiretroviral-experienced (previously treated) adults.

Fixed combination of BIC/FTC/TAF used alone as a complete regimen for treatment of HIV-1 infection; concomitant use with other antiretrovirals not recommended.

For initial treatment in antiretroviral-naive adults, experts state BIC/FTC/TAF is a recommended INSTI-based regimen for most adults.

For antiretroviral-experienced adults, manufacturer states BIC/FTC/TAF can be used to replace the current antiretroviral regimen in those with plasma HIV-1 RNA levels <50 copies/mL on a stable antiretroviral regimen for ≥3 months who have no history of treatment failure and are infected with HIV-1 with no known substitutions associated with resistance to the antiretroviral components of the fixed combination (i.e., bictegravir, emtricitabine, tenofovir).

• Generic Name: alemtuzumab
• Dosage Forms: injection, solution, concentrate
• Other Brand Names: Campath, Lemtrada

Lemtrada is used to treat chronic B-cell lymphocytic leukemia.

Lemtrada is also used to treat relapsing forms of multiple sclerosis in adults (including active secondary progressive disease).

Lemtrada will not cure MS, but it can make relapses occur less often. This medicine is not for use in treating clinically isolated syndrome.

Lemtrada is available only from a certified pharmacy under a special program.

Lemtrada may also be used for purposes not listed in this medication guide.